Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana O Hoff

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Archives of Endocrinology and Metabolism|September 3, 2015
The evolving field of thyroid cancer: refinement of old and creation of new paradigmsAna O Hoff
Hormones & Cancer|January 6, 2016
5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical CarcinomaAna O Hoff, Alfredo Berruti
Hematology/Oncology Clinics of North America|June 6, 2007
Medullary thyroid carcinomaAna O Hoff, Paulo M Hoff
Current Opinion in Oncology|February 21, 2012
Recent advances in the molecular pathogenesis and targeted therapies of medullary thyroid carcinomaMadson Q Almeida, Ana O Hoff
Oncology (Williston Park, N.Y.)|June 11, 2005
Osteoporosis in breast and prostate cancer survivorsAna O Hoff, Robert F Gagel
Endocrine-Related Cancer|October 14, 2017
Endocrine side effects of cancer immunotherapyPriscilla Cukier, Fernando C Santini, Mariana Scaranti, et al.
Journal of Thyroid Research|October 19, 2011
Thyroid oncologyMaria João M Bugalho, Nelson Wohllk, Ana O Hoff, et al.
Archives of Endocrinology and Metabolism|September 8, 2022
Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM)Laura Sterian Ward, Rafael Selbach Scheffel, Ana O Hoff, et al.
Annals of the New York Academy of Sciences|October 16, 2010
Epidemiology and risk factors for osteonecrosis of the jaw in cancer patientsAna O Hoff, Bela Toth, Mimi Hu, et al.
Journal of the Endocrine Society|May 30, 2019
Quality of Life and Coping in Multiple Endocrine Neoplasia Type 2Fernanda A Correa, Evelin C Farias, Luciana A Castroneves, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Archives of Endocrinology and Metabolism|September 3, 2015
The evolving field of thyroid cancer: refinement of old and creation of new paradigmsAna O Hoff
Hormones & Cancer|January 6, 2016
5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical CarcinomaAna O Hoff, Alfredo Berruti
Hematology/Oncology Clinics of North America|June 6, 2007
Medullary thyroid carcinomaAna O Hoff, Paulo M Hoff
Current Opinion in Oncology|February 21, 2012
Recent advances in the molecular pathogenesis and targeted therapies of medullary thyroid carcinomaMadson Q Almeida, Ana O Hoff
Oncology (Williston Park, N.Y.)|June 11, 2005
Osteoporosis in breast and prostate cancer survivorsAna O Hoff, Robert F Gagel
Endocrine-Related Cancer|October 14, 2017
Endocrine side effects of cancer immunotherapyPriscilla Cukier, Fernando C Santini, Mariana Scaranti, et al.
Journal of Thyroid Research|October 19, 2011
Thyroid oncologyMaria João M Bugalho, Nelson Wohllk, Ana O Hoff, et al.
Archives of Endocrinology and Metabolism|September 8, 2022
Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM)Laura Sterian Ward, Rafael Selbach Scheffel, Ana O Hoff, et al.
Annals of the New York Academy of Sciences|October 16, 2010
Epidemiology and risk factors for osteonecrosis of the jaw in cancer patientsAna O Hoff, Bela Toth, Mimi Hu, et al.
Journal of the Endocrine Society|May 30, 2019
Quality of Life and Coping in Multiple Endocrine Neoplasia Type 2Fernanda A Correa, Evelin C Farias, Luciana A Castroneves, et al.
Pageof 8